Marker Therapeutics Inc (MRKR)

[Epicare]

Did they just hire a VP oversight clinical trial and related stuffs? I cannot believe MRKR management team made such a low level mistake for such an important event!!

HOUSTON, Feb. 7, 2019 /PRNewswire/ -- Marker Therapeutics, Inc. (MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced the appointment of Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development. In this role, she will be responsible for clinical development strategy, clinical study design, and medical oversight of the Company's therapeutic product candidates.